Antibody blood-brain barrier efflux is modulated by glycan modification

BACKGROUND: Drug delivery to the brain is a major roadblock to treatment of Alzheimer’s Disease. Recent results of the PRIME study indicate that increasing brain penetration of antibody drugs improves Alzheimer’s treatment outcomes. New approaches are needed to better accomplish this goal. Based on...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Biochim Biophys Acta
Autores principales: Finke, John M., Ayres, Kari R., Brisbin, Ryan P., Hill, Hali A., Wing, Emily E., Banks, William A.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2017
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5557653/
https://ncbi.nlm.nih.gov/pubmed/28624473
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbagen.2017.06.008
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares